Riskpilot← Back to searchSign inGet full accessLill Blomqwist AB
ABActiveOrg 5592873565Magnus Stenbocksgatan 5Hospital activities · NACE 8610Est. 20200 employees
Revenue 2025
SEK 583K
-10% vs 2024
EBITDA margin
84.7%
-8% vs 2024
Equity ratio
45.4%
Financial strength
Net profit 2025
SEK 291K
-16% vs 2024
| Revenue | SEK 583K | -10% |
| EBITDA | SEK 493K | -8% |
| Net profit | SEK 291K | -16% |
| Total assets | SEK 1 000K | +17% |
| Equity | SEK 454K | +22% |
| Employees | 0 | — |
Legal name
Lill Blomqwist AB
Org number
5592873565
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
3 december 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Tillhandahålla tjänster så som arbete som läkare, utbildningsaktiviteter med anknytning till medicin samt vård- och omsorg, finansiella transaktioner, catering, fysisk träning och rådgivning, massage, konstnärlig verksamhet.
Address
Magnus Stenbocksgatan 5
Email
lill.blomqwist@med.lu.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 183 | 585 | 745 | 648 | 583 |
| Staff expenses | — | −4 | −33 | −37 | −32 |
| EBITDA | 142 | 529 | 638 | 536 | 493 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 142 | 529 | 638 | 536 | 493 |
| Net financials | — | −0 | −106 | 27 | −2 |
| Profit before tax | 141 | 529 | 372 | 433 | 371 |
| Tax | −29 | −112 | −101 | −86 | −80 |
| Net profit | 112 | 417 | 272 | 346 | 291 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 173 | 787 | 840 | 855 | 1 000 |
| Equity | 137 | 555 | 326 | 373 | 454 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 35 | 233 | 353 | 192 | 136 |
| Total debt | 35 | 233 | 353 | 192 | 136 |
EBITDA margin
84.7%
This company
15.8%
Market median
+436% vs market
20212025
Equity ratio
45.4%
This company
38.2%
Market median
+19% vs market
20212025
Return on equity
64.2%
This company
18.4%
Market median
+249% vs market
20212025
Net profit margin
50.0%
This company
8.1%
Market median
+517% vs market
20212025
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20212025
Debt / equity
1.20×
This company
0.62×
Market median
-94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LB Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lill Blomqwist AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lill Birgitta Elsie Blomqwist | Chief Executive Officer | 0 companies |
| Sebastian Per Bergenzaun | Deputy Board Member | 0 companies |
| Daniel Bergenzaun | Deputy Board Member | 0 companies |
| Niklas Olof Bergenzaun | Deputy Board Member | 0 companies |
| Niklas Olof Bergenzaun | Deputy Board Member | 0 companies |
| Daniel Erik Bergenzaun | Deputy Board Member | 0 companies |